TY  - BOOK
AU  - Alaa Rizk Sanad Ibrahim Leila
AU  - Ashraf H. Abadi , 
AU  - Mohammad Abdelhalim , 
TI  - Design , synthesis of symmetric molecules as potential anti-HCV agents / 
PY  - 2017///
CY  - Cairo : 
PB  - Alaa Rizk Sanad Ibrahim Leila , 
N1  - Thesis (M.Sc.) - German University - Faculty of  Postgraduate Studies and Scientific Research  - Department of Pharmaceutical Chemistry
N2  - Until recently, the standard therapy for HCV treatment has been a combination of interferon Ü (IFNÜ) and ribavirin (RBV) which has severe side effects and contraindications. Cure rates reported for this combination therapy were about 50%¹{u⁰⁶⁶B}² therefore, direct-acting antivirals (DAAs) were developed to target viral proteins that are crucial for the HCV lifecycle
UR  - http://172.23.153.220/th.pdf
ER  -